Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1996 Nov;224(5):647-64.
doi: 10.1097/00000658-199611000-00009.

Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

W L Biffl  1 , E E Moore, F A Moore, V M Peterson
Affiliations
Review

Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

W L Biffl et al. Ann Surg. 1996 Nov.

Abstract

Objective: The effects of interleukin (IL)-6 in the injured patient are examined in an attempt to clarify the potential pathophysiologic role of IL-6 in the response to injury.

Summary background data: Interleukin-6 is an integral cytokine mediator of the acute phase response to injury and infection. However, prolonged and excessive elevations of circulating IL-6 levels in patients after trauma, burns, and elective surgery have been associated with complications and mortality. The mechanistic role of IL-6 in mediating these effects is unclear.

Methods: A review of current literature is performed to summarize the origins, mechanisms of action, and biologic effects of IL-6 and to characterize the IL-6 response to injury.

Results: Interleukin-6 is a multifunctional cytokine expressed by a variety of cells after a multitude of stimuli, under complex regulatory control mechanisms. The IL-6 response to injury is uniquely consistent and related to the magnitude of the insult. Moreover, the early postinjury IL-6 response correlates with complications as well as mortality.

Conclusions: Interleukin-6 appears to play an active role in the postinjury immune response, making it an attractive therapeutic target in attempts to control hyperinflammatory provoked organ injury.

PubMed Disclaimer

References

    1. J Trauma. 1978 Oct;18(10):696-700 - PubMed
    1. Ann Surg. 1978 Dec;188(6):809-16 - PubMed
    1. Mayo Clin Proc. 1980 Jun;55(6):371-6 - PubMed
    1. Ann Surg. 1980 Dec;192(6):772-5 - PubMed
    1. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7152-6 - PubMed

Publication types